Artículos por temáticas

Benefit and safety of antibiotics for Alzheimer's disease: Protocol for a systematic review and meta-analysis

Gao L, Shuai Y, Wen L, Zhang H, Zhang Y, Zhang X.

Medicine (Baltimore). 2022 Nov 25;101(47):e31637. doi: 10.1097/MD.0000000000031637.

Targeting Microglia in Alzheimer's Disease: From Molecular Mechanisms to Potential Therapeutic Targets for Small Molecules

Althafar ZM.

Molecules. 2022 Jun 27;27(13):4124. doi: 10.3390/molecules27134124.

Carthamus tinctorius L.: A natural neuroprotective source for anti-Alzheimer's disease drugs

Liang Y, Wang L.

J Ethnopharmacol. 2022 Nov 15;298:115656. doi: 10.1016/j.jep.2022.115656. Epub 2022 Aug 27.

Recent updates in the development of small molecules as potential clinical candidates for Alzheimer's disease: A review

Umar T, Meena R, Mustehasan, Kumar P, Khan AA.

Chem Biol Drug Des. 2022 Nov;100(5):674-681. doi: 10.1111/cbdd.14133. Epub 2022 Sep 13.

Blood pressure, antihypertensive drugs, and incident frailty: The Multidomain Alzheimer Preventive Trial (MAPT)

Rouch L, Rolland Y, Hanon O, Vidal JS, Cestac P, Sallerin B, Andrieu S, Vellas B, Barreto PS; MAPT/DSA Group.

Maturitas. 2022 Aug;162:8-14. doi: 10.1016/j.maturitas.2022.03.001. Epub 2022 Mar 15.

Meta analysis of aerobic exercise improving intelligence and cognitive function in patients with Alzheimer's disease

Zhou XP, Zhang LM, Chen GQ, Wang SW, He JF, Li Z, Zhang BS.

Medicine (Baltimore). 2022 Oct 21;101(42):e31177. doi: 10.1097/MD.0000000000031177.

Tackling a Major Deficiency of Diversity in Alzheimer's Disease Therapeutic Trials: An CTAD Task Force Report

Raman R, Aisen PS, Carillo MC, Detke M, Grill JD, Okonkwo OC, Rivera-Mindt M, Sabbagh M, Vellas B, Weiner M, Sperling R.

J Prev Alzheimers Dis. 2022;9(3):388-392. doi: 10.14283/jpad.2022.50.

Technological Solutions for Diagnosis, Management and Treatment of Alzheimer's Disease-Related Symptoms: A Structured Review of the Recent Scientific Literature

Cammisuli DM, Cipriani G, Castelnuovo G.

Int J Environ Res Public Health. 2022 Mar 7;19(5):3122. doi: 10.3390/ijerph19053122.

Incidence of Amyloid-Related Imaging Abnormalities in Patients With Alzheimer Disease Treated With Anti-β-Amyloid Immunotherapy: A Meta-analysis

Jeong SY, Suh CH, Shim WH, Lim JS, Lee JH, Kim SJ.

Neurology. 2022 Nov 8;99(19):e2092-e2101. doi: 10.1212/WNL.0000000000201019. Epub 2022 Aug 29.

A systematic review of the efficacy of donepezil hydrochloride combined with nimodipine on treating vascular dementia

Yang Q, Liu J, Huang KL, Wang GY, Wang MY, Tan AH, Ran SM.

Medicine (Baltimore). 2022 Aug 5;101(31):e29307. doi: 10.1097/MD.0000000000029307.

Cdk5-p25 as a key element linking amyloid and tau pathologies in Alzheimer's disease: Mechanisms and possible therapeutic interventions

Maitra S, Vincent B.

Life Sci. 2022 Nov 1;308:120986. doi: 10.1016/j.lfs.2022.120986. Epub 2022 Sep 21.

Phenolic Acids and Prevention of Cognitive Decline: Polyphenols with a Neuroprotective Role in Cognitive Disorders and Alzheimer's Disease

Caruso G, Godos J, Privitera A, Lanza G, Castellano S, Chillemi A, Bruni O, Ferri R, Caraci F, Grosso G.

Nutrients. 2022 Feb 15;14(4):819. doi: 10.3390/nu14040819.

Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer's Disease

Wu L, Xian X, Xu G, Tan Z, Dong F, Zhang M, Zhang F.

Mediators Inflamm. 2022 Aug 21;2022:7924199. doi: 10.1155/2022/7924199. eCollection 2022.

Mechanistic and therapeutic implications of EphA-4 receptor tyrosine kinase in the pathogenesis of Alzheimer's disease

Ganguly D, Thomas JA, Ali A, Kumar R.

Eur J Neurosci. 2022 Nov;56(9):5532-5546. doi: 10.1111/ejn.15591. Epub 2022 Jan 13.

Forest Biomass as a Promising Source of Bioactive Essential Oil and Phenolic Compounds for Alzheimer's Disease Therapy

Moreira P, Matos P, Figueirinha A, Salgueiro L, Batista MT, Branco PC, Cruz MT, Pereira CF.

Int J Mol Sci. 2022 Aug 8;23(15):8812. doi: 10.3390/ijms23158812.